Carnosine Supplementation and Cardiovascular Function
Effects of Carnosine Supplementation in Form of Capsules and Functional Food on Cardiovascular Function
1 other identifier
interventional
100
1 country
1
Brief Summary
Carnosine is a dipeptide synthesized in the body from β-alanine and L-histidine. It was originally discovered in skeletal muscle where it is present in larger amounts than in other tissues, but it is also found in high concentrations in the brain, heart, and gastrointestinal tissues of humans. Although its physiological role has not been completely understood yet, carnosine is a non-enzymatic free-radical scavenger and a natural antioxidant and has anti-inflammatory and neuroprotective properties. The hypothesis of this research is that the consumption of carnosine supplements in the form of capsules, as well as chicken meat enriched with carnosine (functional food) has a beneficial effect on vascular reactivity measured in different vascular basins, and the lipid profile with a positive effect on the reduction of oxidative stress and inflammatory response in healthy sedentary people. subjects and active athletes measured in different vascular basins. The main goal of this study is to investigate the influence of carnosine supplement consumption (in the form of capsules and functional food) on vascular and endothelial function in a population of healthy young subjects and active athletes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 22, 2023
CompletedFirst Posted
Study publicly available on registry
February 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFebruary 14, 2023
February 1, 2023
1.3 years
January 22, 2023
February 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Microvascular endothelial function
Cutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to vascular occlusion (post occlusive reactive hyperaemia - PORH), in response to iontophoresis of acetylcholine (ACh) and local thermal hyperemia (LTH).
3 weeks
Macrovascular endothelial function
Measurement of flow mediated dilation (FMD) of brachial artery using ultrasound.
3 weeks
Cerebrovascular reactivity
Measurement of cerebrovascular blood flow using transcranial color Doppler (TCD).
3 weeks
Secondary Outcomes (10)
Lipid profile
3 weeks
Oxidative stress status
3 weeks
Systemic hemodynamics
3 weeks
Serum Pro- and Anti-Inflammatory Cytokines, Chemokines, Growth Factors and Soluble Cell Adhesion Molecules Protein Concentration
3 weeks
Body composition
3 weeks
- +5 more secondary outcomes
Study Arms (2)
Carnosine
EXPERIMENTALIntake of carnosine supplement in form of capsules or functionally enriched chicken meet for three weeks
Control
PLACEBO COMPARATORIntake of placebo capsules or regular chicken meet for three weeks
Interventions
Intake of carnosine supplement in form of capsules or functionally enriched chicken meet for three weeks
Eligibility Criteria
You may qualify if:
- young healthy sedentary individuals - did not perform regular physical activities for at least 12 months before conducting the study
- young healthy active athletes - have a minimum of 5 training sessions per week (mainly endurance training) for at least 12 months prior to conducting the study
You may not qualify if:
- smoking
- hypertension
- coronary disease
- diabetes
- hyperlipidemia
- kidney damage
- cerebrovascular and peripheral artery diseases
- and any other disease that could have an impact on vascular and endothelial function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Scientific Center of Excellence for Personalized Health Care, Josip Juraj Strossayer University of Osijek
Osijek, 31000, Croatia
Related Publications (1)
Peric L, Drenjancevic I, Jukic I, Boris A, Susnjara P, Kolobaric N, Mihaljevic Z, Kralik Z, Kralik G, Kosevic M, Galovic O, Stupin A. Carnosine-enriched functional food enhances micro- and macrovascular endothelium-independent vasodilation in competitive athletes-a randomized study. Appl Physiol Nutr Metab. 2025 Jan 1;50:1-11. doi: 10.1139/apnm-2024-0458.
PMID: 39983097DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 22, 2023
First Posted
February 13, 2023
Study Start
September 1, 2022
Primary Completion
December 31, 2023
Study Completion
June 30, 2024
Last Updated
February 14, 2023
Record last verified: 2023-02